Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Vermersch

Showing results (21-30 of 250) with videos related to

Pageof 25
Sort By:
Multiple Sclerosis and Related Disorders|September 25, 2020
An analysis of first-line disease-modifying therapies in patients with relapsing-remitting multiple sclerosis using the French nationwide health claims database from 2014-2017Patrick Vermersch, Laurent Suchet, Renato Colamarino, et al.
Muscle & Nerve|February 16, 2011
Recurrent multiple cranial nerve palsy and anti-GD1a antibodiesOlivier Simon, Arnaud Lacour, Arnaud Delval, et al.
Acta Neurologica Belgica|December 19, 2016
Autoimmune cerebellar ataxia with glutamic acid decarboxylase 65 antibodies associated with central vestibular symptomsFrédéric London, Nawal Hadhoum, Hélène Zéphir, et al.
Acta Neurologica Belgica|August 12, 2016
Isaacs' syndrome and Hodgkin lymphoma: a rare associationFrédéric London, Jean-Baptiste Bancilhon, Céline Tard, et al.
Acta Dermato-Venereologica|November 9, 2007
Periorbital ecchymoses are not pathognomonic of the light-chain type of amyloidosisOlivier Outteryck, Tanya Stojkovic, David Launay, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 2, 2015
A comparative optical coherence tomography study in neuromyelitis optica spectrum disorder and multiple sclerosisOlivier Outteryck, Bilal Majed, Sabine Defoort-Dhellemmes, et al.
The Lancet. Neurology|January 24, 2026
Patient-reported outcomes and multiple sclerosis therapiesPaola Zaratin, Daniel Ontaneda, Maria Pia Amato, et al.
Frontiers in Neurology|August 12, 2021
Effectiveness, Healthcare Resource Utilization and Adherence to Subcutaneous Interferon Beta-1a According to Age in Patients With Multiple Sclerosis: A Cohort Study Using a US Claims DatabaseArthur Allignol, Emmanuelle Boutmy, Meritxell Sabidó Espin, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 12, 2021
Durability of no evidence of disease activity-3 (NEDA-3) in patients receiving cladribine tablets: The CLARITY extension studyGavin Giovannoni, Barry A Singer, Delphine Issard, et al.
Ochsner Journal|January 7, 2020
A Rare and Treatable Cause of Medullar Claudication: Spinal Dural Arteriovenous FistulaCeline Derollez, Celine Tard, Apolline Kazémi, et al.
Pageof 25

Showing results (21-30 of 250) with videos related to

Sort By:
Pageof 25
Multiple Sclerosis and Related Disorders|September 25, 2020
An analysis of first-line disease-modifying therapies in patients with relapsing-remitting multiple sclerosis using the French nationwide health claims database from 2014-2017Patrick Vermersch, Laurent Suchet, Renato Colamarino, et al.
Muscle & Nerve|February 16, 2011
Recurrent multiple cranial nerve palsy and anti-GD1a antibodiesOlivier Simon, Arnaud Lacour, Arnaud Delval, et al.
Acta Neurologica Belgica|December 19, 2016
Autoimmune cerebellar ataxia with glutamic acid decarboxylase 65 antibodies associated with central vestibular symptomsFrédéric London, Nawal Hadhoum, Hélène Zéphir, et al.
Acta Neurologica Belgica|August 12, 2016
Isaacs' syndrome and Hodgkin lymphoma: a rare associationFrédéric London, Jean-Baptiste Bancilhon, Céline Tard, et al.
Acta Dermato-Venereologica|November 9, 2007
Periorbital ecchymoses are not pathognomonic of the light-chain type of amyloidosisOlivier Outteryck, Tanya Stojkovic, David Launay, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 2, 2015
A comparative optical coherence tomography study in neuromyelitis optica spectrum disorder and multiple sclerosisOlivier Outteryck, Bilal Majed, Sabine Defoort-Dhellemmes, et al.
The Lancet. Neurology|January 24, 2026
Patient-reported outcomes and multiple sclerosis therapiesPaola Zaratin, Daniel Ontaneda, Maria Pia Amato, et al.
Frontiers in Neurology|August 12, 2021
Effectiveness, Healthcare Resource Utilization and Adherence to Subcutaneous Interferon Beta-1a According to Age in Patients With Multiple Sclerosis: A Cohort Study Using a US Claims DatabaseArthur Allignol, Emmanuelle Boutmy, Meritxell Sabidó Espin, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 12, 2021
Durability of no evidence of disease activity-3 (NEDA-3) in patients receiving cladribine tablets: The CLARITY extension studyGavin Giovannoni, Barry A Singer, Delphine Issard, et al.
Ochsner Journal|January 7, 2020
A Rare and Treatable Cause of Medullar Claudication: Spinal Dural Arteriovenous FistulaCeline Derollez, Celine Tard, Apolline Kazémi, et al.
Pageof 25